Hi, As this board has moderate frequency I would like to share some infos I know about this company. Happy to discuss.
This company is one of two listed companies which is allowed to produce and sell medical marijuana. The other one is "the hydroponics company (AU000000THC4). I don't know how hard it is to get a license in Australia, but since they are listed, they receive a lot of capital through the financial market to fund the operations and to increase market share. I do not see major competition-threat.
But! Cann Group get backed by Aurora. With 16% ownership, they must have a significant voice in management. 35% of shares are hold by management and other institutions. the rest is floating. This numbers are pre-placement. So I didn't calculate the new onwership-structure after the placement of 60mln. But still. 50% held by instis? this is a huge number and makes this share very sensitive in aspect of price changes. This is not always a good thing, but this stock has kind of a floor @2,50 AUD (price of new shares) too. Of course they can't absorb to much bad news, but it helps.
But there is one argument which makes me nervous. Valuation relative to the time the company is listed. Cann is still in the developing stage, and has 250mln USD valuation? This is a very high premium. thats double of the valuation canopy had , when they started to make revenue. But Cann Group did not publish any forecasts... I hope the ownership and competition argument cost that much.